Tyra Biosciences, Inc. (TYRA)
33.02
-0.38
(-1.14%)
USD |
NASDAQ |
May 21, 16:00
33.00
-0.02
(-0.06%)
After-Hours: 19:59
Tyra Biosciences Research and Development Expense (TTM) : 110.89M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Spyre Therapeutics, Inc. | 190.44M |
| Relay Therapeutics, Inc. | 258.14M |
| Tango Therapeutics, Inc. | 127.14M |
| Entrada Therapeutics, Inc. | 137.56M |
| BioMarin Pharmaceutical, Inc. | 721.03M |